Evidence map›Paper›PMID 30882720›Full record

ArticleThe Pediatric infectious disease journal2019

Immunologic-based Diagnosis of Latent Tuberculosis Among Children Younger Than 5 Years of Age Exposed and Unexposed to Tuberculosis in Tanzania.

Khadija Said, Jerry Hella, Mwajabu Ruzegea, Rajesh Solanki, Magreth Chiryamkubi, Francis Mhimbira, Nicole Ritz, Christian Schindler, Anna M Mandalakas, Karim Manji and 3 more

Abstract read
In one paragraph

Article in The Pediatric infectious disease journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Performance of a household tuberculosis exposure survey among children in a Latin American setting.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 3 countries.

Khadija SaidFrom the Ifakara Health Institute, Bagamoyo Research and Training Centre, Bagamoyo, Tanzania.
Jerry HellaFrom the Ifakara Health Institute, Bagamoyo Research and Training Centre, Bagamoyo, Tanzania.
Mwajabu RuzegeaFrom the Ifakara Health Institute, Bagamoyo Research and Training Centre, Bagamoyo, Tanzania.
Rajesh SolankiTemeke Municipal Council Hospital, Dar es Salaam, Tanzania.
Magreth ChiryamkubiNational Tuberculosis and Leprosy Control Program, Dar es Salaam, Tanzania.
Francis MhimbiraFrom the Ifakara Health Institute, Bagamoyo Research and Training Centre, Bagamoyo, Tanzania.
Nicole RitzUniversity of Basel, Basel, Switzerland.
Christian SchindlerSwiss Tropical and Public Health Institute, Basel, Switzerland.
Anna M MandalakasThe Global Tuberculosis Program, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas.
Karim ManjiMuhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Marcel TannerSwiss Tropical and Public Health Institute, Basel, Switzerland.
Jürg UtzingerSwiss Tropical and Public Health Institute, Basel, Switzerland.
Lukas FennerInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Ifakara Health Institute · TZUniversity of Basel · CHSwiss Tropical and Public Health Institute · CHMuhimbili University of Health and Allied Sciences · TZTemeke Municipal Council · TZTexas Children's Hospital · USUniversity of Bern · CH

Funding

Quantifiable stool-based TB PCR to Improve Diagnostics and Treatment MonitoringR01AI137527 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI MANDALAKAS, ANNA M · 2019 to 2022
$2.7M
NIAID NIH HHS R01 AI137527
6 · The paper itself

Abstract

backgroundChildhood tuberculosis (TB) is acquired after exposure to an infectious TB case, often within the household. We prospectively screened children 6-59 months of age, exposed and unexposed to an infectious TB case within the same household, for latent tuberculosis infection (LTBI), in Dar es Salaam, Tanzania.

methodsWe collected medical data and clinical specimens (to evaluate for helminths, TB and HIV coinfections) and performed physical examinations at enrollment and at 3-month and 6-month follow-up surveys. LTBI was assessed using QuantiFERON-TB Gold (QFT) at enrollment and at 3 months.

resultsIn total, 301 children had complete data records (186 with TB exposure and 115 without known TB exposure). The median age of children was 26 months (range: 6-58); 52% were females, and 4 were HIV positive. Eight children (3%) developed TB during the 6-month follow-up. We found equal proportions of children with LTBI among those with and without exposure: 20% (38/186) versus 20% (23/115) QFT-positive, and 2% (4/186) versus 4% (5/115) indeterminate QFT. QFT conversion rate was 7% (22 children) and reversion 8% (25 children). Of the TB-exposed children, 72% initiated isoniazid preventive therapy, but 61% of parents/caregivers of children with unknown TB exposure and positive QFT refused isoniazid preventive therapy.

conclusionsIn this high burden TB setting, TB exposure from sources other than the household was equally important as household exposure. Nearly one third of eligible children did not receive isoniazid preventive therapy. Evaluation for LTBI in children remains an important strategy for controlling TB but should not be limited to children with documented TB exposure.

Indexed as

Antitubercular AgentsChildChild, PreschoolDiagnostic Tests, RoutineFemaleHumansInfantInterferon-gamma Release TestsLatent TuberculosisMalePrevalenceProspective StudiesTanzaniaAntitubercular Agents

Identifiers

PMID30882720
PMCPMC12190722
OpenAlexW2810377847

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.